Literature DB >> 2136208

Ontogenic appearance of MHC class I (B-F) antigens during chicken embryogenesis.

D Dunon1, J Salomonsen, K Skjødt, J Kaufman, B A Imhof.   

Abstract

Expression of chicken MHC class I (B-F) antigens during ontogeny was determined by binding of anticlass I antibody and appearance of B-F transcripts by Northern blotting in chicken organs during embryogenesis until 2 weeks after hatching. MHC class I transcripts first become detectable in day 6.5 of embryogenesis. B-F cell-surface expression first becomes detectable in hemopoietic organs by day 10-12 of embryogenesis and somewhat later in nonhemopoietic organs. Flow cytometry analysis of hemopoietic cells throughout embryogenesis revealed B-Fhi and B-Flo cell populations. The percentage of B-F+ cells in spleen and bone marrow decreased around hatching, which could reflect either cell flows in these organs during this period or the sensitivity of hemopoietic cells to hatching stress.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136208      PMCID: PMC2275823          DOI: 10.1155/1990/75158

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  3 in total

1.  Two class I genes of the chicken MHC have different functions: BF1 is recognized by NK cells while BF2 is recognized by CTLs.

Authors:  Taejoong Kim; Henry D Hunt; Mark S Parcells; Vicky van Santen; Sandra J Ewald
Journal:  Immunogenetics       Date:  2018-06-09       Impact factor: 2.846

2.  At least one YMHCI molecule in the chicken is alloimmunogenic and dynamically expressed on spleen cells during development.

Authors:  Henry D Hunt; Ronald M Goto; Douglas N Foster; Larry D Bacon; Marcia M Miller
Journal:  Immunogenetics       Date:  2006-03-28       Impact factor: 2.846

3.  Chicken major histocompatibility complex-encoded B-G antigens are found on many cell types that are important for the immune system.

Authors:  J Salomonsen; D Dunon; K Skjødt; D Thorpe; O Vainio; J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.